Neurotensin Receptor Agonists and Antagonists for Schizophrenia
Gespeichert in:
| Veröffentlicht in: | The American journal of psychiatry 2005-03, Vol.162 (3), p.633-b-634 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 634 |
|---|---|
| container_issue | 3 |
| container_start_page | 633-b |
| container_title | The American journal of psychiatry |
| container_volume | 162 |
| creator | RICHELSON, ELLIOTT FREDRICKSON, PAUL A. BOULES, MONA M. |
| description | |
| doi_str_mv | 10.1176/appi.ajp.162.3.633-b |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67473897</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67473897</sourcerecordid><originalsourceid>FETCH-LOGICAL-a347t-67c5bf791adc4a848e547b73a864d94f8bed05ae4a104b9f0a6b653c32e874a63</originalsourceid><addsrcrecordid>eNp9kMtKw0AUhgdRbK2-gUhW7hJnMrdkJaXUCxQFL-BuOJNMbEo7E2eShT69U1tx5-pwON__w_kQOic4I0SKK-i6NoNVlxGRZzQTlKb6AI0JpzyVeV4cojHGOE9LTt9G6CSEVVwxlfkxGhEuGWFlOUbXD2bwrjc2tDZ5MpXpeueT6buzbehDArZOpraH372Jx-dq2X65bumNbeEUHTWwDuZsPyfo9Wb-MrtLF4-397PpIgXKZJ8KWXHdyJJAXTEoWGE4k1pSKASrS9YU2tSYg2FAMNNlg0FowWlFc1NIBoJO0OWut_PuYzChV5s2VGa9BmvcEJSQTNKilBFkO7DyLgRvGtX5dgP-UxGstuLUVpyK4lQUp6iK4pSOsYt9_6A3pv4L7U1FgOyAn_jKDd7Gf_8pTTX9BhlZfQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67473897</pqid></control><display><type>article</type><title>Neurotensin Receptor Agonists and Antagonists for Schizophrenia</title><source>MEDLINE</source><source>American Psychiatric Publishing Journals (1997-Present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>RICHELSON, ELLIOTT ; FREDRICKSON, PAUL A. ; BOULES, MONA M.</creator><creatorcontrib>RICHELSON, ELLIOTT ; FREDRICKSON, PAUL A. ; BOULES, MONA M.</creatorcontrib><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/appi.ajp.162.3.633-b</identifier><identifier>PMID: 15741499</identifier><language>eng</language><publisher>United States: American Psychiatric Publishing</publisher><subject>Animals ; Antipsychotic Agents - therapeutic use ; Blood-Brain Barrier - drug effects ; Clinical Trials as Topic ; Drugs, Investigational - pharmacokinetics ; Drugs, Investigational - therapeutic use ; Humans ; Neurotensin - analogs & derivatives ; Neurotensin - pharmacokinetics ; Neurotensin - therapeutic use ; Peptide Fragments - pharmacokinetics ; Peptide Fragments - therapeutic use ; Pyrazoles - therapeutic use ; Quinolines - therapeutic use ; Receptors, Neurotensin - agonists ; Receptors, Neurotensin - antagonists & inhibitors ; Schizophrenia - drug therapy ; Treatment Outcome</subject><ispartof>The American journal of psychiatry, 2005-03, Vol.162 (3), p.633-b-634</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a347t-67c5bf791adc4a848e547b73a864d94f8bed05ae4a104b9f0a6b653c32e874a63</citedby><cites>FETCH-LOGICAL-a347t-67c5bf791adc4a848e547b73a864d94f8bed05ae4a104b9f0a6b653c32e874a63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/appi.ajp.162.3.633-b$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/appi.ajp.162.3.633-b$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,777,781,2842,21607,21608,21609,27905,27906,77543,77548</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15741499$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RICHELSON, ELLIOTT</creatorcontrib><creatorcontrib>FREDRICKSON, PAUL A.</creatorcontrib><creatorcontrib>BOULES, MONA M.</creatorcontrib><title>Neurotensin Receptor Agonists and Antagonists for Schizophrenia</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><subject>Animals</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Blood-Brain Barrier - drug effects</subject><subject>Clinical Trials as Topic</subject><subject>Drugs, Investigational - pharmacokinetics</subject><subject>Drugs, Investigational - therapeutic use</subject><subject>Humans</subject><subject>Neurotensin - analogs & derivatives</subject><subject>Neurotensin - pharmacokinetics</subject><subject>Neurotensin - therapeutic use</subject><subject>Peptide Fragments - pharmacokinetics</subject><subject>Peptide Fragments - therapeutic use</subject><subject>Pyrazoles - therapeutic use</subject><subject>Quinolines - therapeutic use</subject><subject>Receptors, Neurotensin - agonists</subject><subject>Receptors, Neurotensin - antagonists & inhibitors</subject><subject>Schizophrenia - drug therapy</subject><subject>Treatment Outcome</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKw0AUhgdRbK2-gUhW7hJnMrdkJaXUCxQFL-BuOJNMbEo7E2eShT69U1tx5-pwON__w_kQOic4I0SKK-i6NoNVlxGRZzQTlKb6AI0JpzyVeV4cojHGOE9LTt9G6CSEVVwxlfkxGhEuGWFlOUbXD2bwrjc2tDZ5MpXpeueT6buzbehDArZOpraH372Jx-dq2X65bumNbeEUHTWwDuZsPyfo9Wb-MrtLF4-397PpIgXKZJ8KWXHdyJJAXTEoWGE4k1pSKASrS9YU2tSYg2FAMNNlg0FowWlFc1NIBoJO0OWut_PuYzChV5s2VGa9BmvcEJSQTNKilBFkO7DyLgRvGtX5dgP-UxGstuLUVpyK4lQUp6iK4pSOsYt9_6A3pv4L7U1FgOyAn_jKDd7Gf_8pTTX9BhlZfQA</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>RICHELSON, ELLIOTT</creator><creator>FREDRICKSON, PAUL A.</creator><creator>BOULES, MONA M.</creator><general>American Psychiatric Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050301</creationdate><title>Neurotensin Receptor Agonists and Antagonists for Schizophrenia</title><author>RICHELSON, ELLIOTT ; FREDRICKSON, PAUL A. ; BOULES, MONA M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a347t-67c5bf791adc4a848e547b73a864d94f8bed05ae4a104b9f0a6b653c32e874a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Blood-Brain Barrier - drug effects</topic><topic>Clinical Trials as Topic</topic><topic>Drugs, Investigational - pharmacokinetics</topic><topic>Drugs, Investigational - therapeutic use</topic><topic>Humans</topic><topic>Neurotensin - analogs & derivatives</topic><topic>Neurotensin - pharmacokinetics</topic><topic>Neurotensin - therapeutic use</topic><topic>Peptide Fragments - pharmacokinetics</topic><topic>Peptide Fragments - therapeutic use</topic><topic>Pyrazoles - therapeutic use</topic><topic>Quinolines - therapeutic use</topic><topic>Receptors, Neurotensin - agonists</topic><topic>Receptors, Neurotensin - antagonists & inhibitors</topic><topic>Schizophrenia - drug therapy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RICHELSON, ELLIOTT</creatorcontrib><creatorcontrib>FREDRICKSON, PAUL A.</creatorcontrib><creatorcontrib>BOULES, MONA M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RICHELSON, ELLIOTT</au><au>FREDRICKSON, PAUL A.</au><au>BOULES, MONA M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurotensin Receptor Agonists and Antagonists for Schizophrenia</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>162</volume><issue>3</issue><spage>633-b</spage><epage>634</epage><pages>633-b-634</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><cop>United States</cop><pub>American Psychiatric Publishing</pub><pmid>15741499</pmid><doi>10.1176/appi.ajp.162.3.633-b</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-953X |
| ispartof | The American journal of psychiatry, 2005-03, Vol.162 (3), p.633-b-634 |
| issn | 0002-953X 1535-7228 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67473897 |
| source | MEDLINE; American Psychiatric Publishing Journals (1997-Present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Animals Antipsychotic Agents - therapeutic use Blood-Brain Barrier - drug effects Clinical Trials as Topic Drugs, Investigational - pharmacokinetics Drugs, Investigational - therapeutic use Humans Neurotensin - analogs & derivatives Neurotensin - pharmacokinetics Neurotensin - therapeutic use Peptide Fragments - pharmacokinetics Peptide Fragments - therapeutic use Pyrazoles - therapeutic use Quinolines - therapeutic use Receptors, Neurotensin - agonists Receptors, Neurotensin - antagonists & inhibitors Schizophrenia - drug therapy Treatment Outcome |
| title | Neurotensin Receptor Agonists and Antagonists for Schizophrenia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A13%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurotensin%20Receptor%20Agonists%20and%20Antagonists%20for%20Schizophrenia&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=RICHELSON,%20ELLIOTT&rft.date=2005-03-01&rft.volume=162&rft.issue=3&rft.spage=633-b&rft.epage=634&rft.pages=633-b-634&rft.issn=0002-953X&rft.eissn=1535-7228&rft_id=info:doi/10.1176/appi.ajp.162.3.633-b&rft_dat=%3Cproquest_cross%3E67473897%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67473897&rft_id=info:pmid/15741499&rfr_iscdi=true |